Contract award · 10 Mar 2021

Trastuzumab (Herceptin®) 600mg/5ml solution for Injection

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded “Trastuzumab (Herceptin®) 600mg/5ml solution for Injection” to Roche Products Ltd for £27.1m on 10 Mar 2021. Awarded without open competition.

No competition
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · Body governed by public law
Supplier
Roche Products Ltd SME
Value
£27,141,272
Contract date
10 Mar 2021
Published
11 Mar 2021
Procedure
Negotiated without publication of a contract notice
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Official notice
004908-2021 on Find a Tender

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

Description

The supply of Trastuzumab (Herceptin®) 600mg/5ml solution for Injection to NHS Scotland.

About the supplier

More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

All contracts →
Date Contract Supplier Value
19 Feb 2021 National Inventory Management Solution Genesis Automation £5.14m
17 Feb 2021 Supply of Triumeq® No competition ViiV Healthcare UK Ltd £10.3m
3 Feb 2021 Additional Call Centre Capacity Advice Direct Scotland SME, Ascensos +7 more £60m
1 Feb 2021 Supply of Triumeq® No competition ViiV Healthcare UK Ltd £10.3m
27 Jan 2021 NP14220 Neonatal and Paediatric Tracheostomy Tubes No competition Smiths Medical International Ltd £300k

More won by Roche Products Ltd

All contracts →

Recent medical equipment & pharmaceuticals contracts

Sector overview →